{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T01:32:03Z","timestamp":1776303123104,"version":"3.50.1"},"reference-count":30,"publisher":"S. Karger AG","issue":"1","license":[{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologica"],"published-print":{"date-parts":[[2022]]},"abstract":"<jats:p>&lt;b&gt;&lt;i&gt;Importance:&lt;\/i&gt;&lt;\/b&gt; Polypoidal choroidal vasculopathy (PCV) is far less common and studied in a Caucasian population than in an Asian population, and the optimal treatment approach remains to be confirmed. &lt;b&gt;&lt;i&gt;Methods:&lt;\/i&gt;&lt;\/b&gt; A 52-week, double-masked, sham-controlled, phase 4, investigator-initiated randomized clinical trial (RCT) in naive symptomatic Caucasian patients with PCV treated with aflibercept in a treat-and-extend regimen (T&amp;amp;E) (intravitreal aflibercept injection [IVAI] T&amp;amp;E). Patients were randomized at week 16 to receive IVAI T&amp;amp;E plus either sham photodynamic therapy (PDT) or standard fluence PDT with verteporfin. The main outcome measures were changes in best-corrected visual acuity (BCVA) from baseline to 52 weeks and polyp occlusion at week 52. Data are presented as median (interquartile range [IQR]) for BCVA, number of IVAI, and change in central retinal thickness (CRT). &lt;b&gt;&lt;i&gt;Results:&lt;\/i&gt;&lt;\/b&gt; Of the 50 patients included in the study, 48 patients completed the 52 weeks of follow-up. During this period, a significant median (IQR) BCVA gain of 6 [2\u201312] Early Treatment Diabetic Retinopathy Study letters was observed for all patients (&lt;i&gt;p&lt;\/i&gt; &amp;#x3c; 0.001), after 8 (7\u20139) injections, with a significant reduction of \u221293.0 [\u2212154.0, \u221244.0] \u00b5m in central macular thickness (&lt;i&gt;p&lt;\/i&gt; &amp;#x3c; 0.001). Using indocyanine green angiography, a complete occlusion of polypoidal lesions was documented in 72% of the cases. Still, no significant difference was detected between the sham PDT and the aflibercept PDT arms, at week 52, for BCVA change (6.5 [2\u201311] vs. 5 [2\u201313] letters (&lt;i&gt;p&lt;\/i&gt; = 0.98)), number of IVAIs (8.5 [7\u20139] vs. 8 [7\u20139] (&lt;i&gt;p&lt;\/i&gt; = 0.21)), change in CRT (\u2212143 [\u2212184; \u221247] vs. \u221289 [\u2212123; \u221241.5] \u00b5m [&lt;i&gt;p&lt;\/i&gt; = 0.23]), and rates of complete polyp occlusion: 77 versus 68% (&lt;i&gt;p&lt;\/i&gt; = 0.53) or presence of fluid: 68 versus 57% (&lt;i&gt;p&lt;\/i&gt; = 0.56). No serious ocular adverse events were registered in the 2 arms. &lt;b&gt;&lt;i&gt;Conclusions and Relevance:&lt;\/i&gt;&lt;\/b&gt; To our knowledge, this is the first RCT to compare aflibercept T&amp;amp;E monotherapy with aflibercept T&amp;amp;E plus verteporfin PDT in a Caucasian population with PCV. Aflibercept monotherapy in a T&amp;amp;E showed to be effective and safe with a significant median BCVA improvement of 6 letters and a complete occlusion of polypoidal lesions in near 3 quarters of the eyes, at 1 year. As only 22% of the eyes underwent PDT treatment, the benefit of combined treatment for PCV in Caucasian patients could not be definitively elucidated from this study. &lt;b&gt;&lt;i&gt;Trial Registration:&lt;\/i&gt;&lt;\/b&gt; The clinical trial was registered in ClinicalTrials.gov Identifier NCT02495181 and the European Union Drug Regulating Authorities Clinical Trials Database EudraCT No. 2015-001368-20. <\/jats:p>","DOI":"10.1159\/000518235","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T21:00:37Z","timestamp":1626210037000},"page":"80-90","source":"Crossref","is-referenced-by-count":12,"title":["Efficacy and Safety of Intravitreal Aflibercept Treat and Extend for Polypoidal Choroidal Vasculopathy in the ATLANTIC Study: A Randomized Clinical Trial"],"prefix":"10.1159","volume":"245","author":[{"given":"Rufino","family":"Silva","sequence":"first","affiliation":[]},{"given":"Luis","family":"Arias","sequence":"additional","affiliation":[]},{"given":"Sandrina","family":"Nunes","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4596-0913","authenticated-orcid":false,"given":"Claudia","family":"Farinha","sequence":"additional","affiliation":[]},{"given":"Rita","family":"Coimbra","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o P.","family":"Marques","sequence":"additional","affiliation":[]},{"given":"Maria L.","family":"Cachulo","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3511-1515","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Figueira","sequence":"additional","affiliation":[]},{"given":"Patricia","family":"Barreto","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6282-3553","authenticated-orcid":false,"given":"Maria H.","family":"Madeira","sequence":"additional","affiliation":[]},{"given":"Isabel","family":"Pires","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o C.","family":"Sousa","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2319-1324","authenticated-orcid":false,"given":"Laura","family":"Distefano","sequence":"additional","affiliation":[]},{"given":"Paulo","family":"Rosa","sequence":"additional","affiliation":[]},{"given":"\u00c2ngela","family":"Carneiro","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6125-5486","authenticated-orcid":false,"given":"Sara","family":"Vaz-Pereira","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9148-2786","authenticated-orcid":false,"given":"Angelina","family":"Meireles","sequence":"additional","affiliation":[]},{"given":"Francisco","family":"Cabrera","sequence":"additional","affiliation":[]},{"given":"Anniken","family":"Bures","sequence":"additional","affiliation":[]},{"given":"Lu\u00eds","family":"Mendon\u00e7a","sequence":"additional","affiliation":[]},{"given":"Alvaro","family":"Fernandez-Vega-Sanz","sequence":"additional","affiliation":[]},{"given":"Sandra","family":"Barr\u00e3o","sequence":"additional","affiliation":[]},{"given":"Adrian","family":"Koh","sequence":"additional","affiliation":[]},{"given":"Chui Ming Gemmy","family":"Cheung","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 G.","family":"Cunha-Vaz","sequence":"additional","affiliation":[]},{"given":"Joaquim","family":"Murta","sequence":"additional","affiliation":[]},{"name":"for the EVICR.net ATLANTIC Study Group","sequence":"additional","affiliation":[]}],"member":"127","published-online":{"date-parts":[[2021,7,13]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1997.01100150480005"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2017.4030"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2016.04.002"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.11.019"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s004170000180"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-020-0834-z"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2019.04.018"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001872"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000355488"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.05.012"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31550-2"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2020-317537"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13461"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-020-04844-z"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13646"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e31824f91e8"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2020.2443"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-005-1139-4"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3182852446"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2018.1804"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2019.02.027"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-7820"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2008.01791.x"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4155\/cli.11.13"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2014-305674"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000229"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2014-305275"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2015.01.018"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-016-0478-5"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000526"}],"container-title":["Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/518235","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/518235","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T15:12:51Z","timestamp":1745421171000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000518235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,13]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,3,1]]},"published-print":{"date-parts":[[2022,3,8]]}},"URL":"https:\/\/doi.org\/10.1159\/000518235","archive":["Portico"],"relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.6084\/m9.figshare.14958822","asserted-by":"subject"}]},"ISSN":["0030-3755","1423-0267"],"issn-type":[{"value":"0030-3755","type":"print"},{"value":"1423-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,13]]}}}